GDF2 and pulmonary arterial hypertension: If sotatercept also sequesters BMP9 and BMP10, this “off-target” effect could reduce endothelial BMP9/10 signaling and, much like the BMP9/10 blocking antibody mouse models of HHT, lead to the HHT-like phenotype seen in these PAH patients.